Objective To evaluate the clinical characteristics, therapeutic interventions, and outcomes of patients with septic shock admitted to the emergency department (ED).
INTRODUCTION
Shock refers to circulatory failure with inadequate tissue perfusion and cellular oxygen utilization. 1 Sepsis is the most common cause of noncardiogenic shock, which is accompanied by lifethreatening organ dysfunction due to dysregulated host response to infection. [1] [2] [3] Despite current advances in intensive care and sepsis therapy, the incidence of sepsis continues to rise and mortality rates in patients with septic shock exceed 20%. 4, 5 With no specific superior therapeutic options being developed, further research and clinical quality improvement are needed to increase the survival of patients with septic shock. 6, 7 The Korean Shock Society (KoSS) was established in 2013 to research and improve clinical quality in the diagnosis and treatment of shock, which is a principal topic in emergency and critical care medicine. The KoSS has been prospectively collecting data in a septic shock registry since October 2015 as a first step towards future research on shock. The KoSS septic shock registry data include clinical characteristics and initial management of, and early outcomes in patients presenting to emergency departments (EDs) with septic shock. This study is a preliminary, descriptive analysis of the KoSS septic shock registry.
METHODS

Study design
This prospective, multi-center, observational study was designed to evaluate the clinical characteristics, therapeutic interventions, and outcomes of patients with septic shock in EDs. Among hospitals in the KoSS, 10 EDs participated in the KoSS septic shock registry from October 2015 to June 2016 (Table 1) . Patients aged 19 years or older who visited one of these EDs and met the eligibility criteria were enrolled. The inclusion criteria included suspected or confirmed infection and evidence of refractory hypotension or hypoperfusion. [8] [9] [10] Systemic inflammatory response syndrome criteria were not obligatory for enrollment. 11 Hypotension was defined as a systolic blood pressure < 90 mmHg, a mean arterial pressure < 70 mmHg, or a systolic blood pressure decrease > 40 mmHg. 6 Refractory hypotension was defined as persistent hypotension after intravenous fluid challenge (1 L or more administered over 30 minutes) or as the need for vasopressors after fluid resuscitation. Hypoperfusion was defined as a serum lactate concentration of 4 mmol/L or greater. Patients who signed a "Do not attempt resuscitation" order before ED arrival or at the time of diagnosis, met the inclusion criteria 6 hours after ED arrival, were transferred from other hospitals without meeting the inclusion criteria upon ED arrival, or were directly transferred from EDs to other hospitals were excluded from this study. The study was approved by the institutional review boards of the individual participating centers and informed consent was obtained according to local institutional review board policy.
Data collection
All data were anonymized and collected using standardized case report forms by research coordinators or physicians at each participating hospital. For data quality control, data were centrally reviewed at the coordinating hospital and case report instructions were provided via manuals and training meetings. The following 
Statistical analyses
The results are presented as medians with interquartile ranges (IQRs) for continuous variables and as the numbers of patients and percentages for categorical data. Continuous and categorical variables were analyzed using Wilcoxon rank-sum and chi-square 
RESULTS
Baseline characteristics and laboratory data
A total of 468 patients with suspected septic shock were enrolled. We excluded patients with "Do not attempt resuscitation" orders (n = 60), those who met the inclusion criteria six hours after ED arrival (n = 44), those who were directly transferred from EDs to other hospitals (n = 32), those who were transferred from other hospitals without meeting the inclusion criteria upon ED arrival (n = 13), and those who had not provided informed consent (n = 460).
The baseline characteristics and comparisons between survivors and non-survivors according to hospital mortality are shown in Table 2 . The median age was 71.3 years (IQR, 59.9 to 78.9) and 258 (55.1%) patients were male. Of the enrolled patients, 388 (82.9%) had refractory hypotension and 80 (17.1%) had hyperlactatemia without hypotension on initial presentation. Respiratory infections (31.0%), intra-abdominal infections (24.6%), and urinary tract infections (21.1%) were the most common sources of infection. Bacteremia was present in 198 (42.4%) patients. The median maximum SOFA score was 7.5 (IQR, 5 to 10.5) and median APACHE II score was 18.5 (IQR, 13 to 25). Between survivors and non-survivors, there were significant differences in variables including sex, initial presentation, chronic renal disease, hematologic malignancy, suspected infection focus, respiratory rate, heart rate, body temperature, SOFA score, and APACHE II score.
The laboratory results are shown in Table 3 , including complete blood count, blood chemistry, and lactate level. The median lactate level was 3.1 mmol/L (IQR, 1.8 to 5.0) on initial measurement (n = 458) and 2.5 mmol/L (IQR, 1.6 to 4.5) at the second measurement (n = 353). 
Interventions
The interventions or procedures for the diagnosis and management of septic shock are shown in Missing data: one case, time to lactate measurement; five cases, time to antibiotics; six cases, time to vasopressors; 11 cases, time to mechanical ventilation; three cases, duration of mechanical ventilation; and seven cases, time to source control.
b) The sepsis bundle components. Cases without hypotension were considered as the bundle component was achieved.
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initial three hours of ED arrival, lactate measurement was performed in 427 (91.2%) patients, blood culture was done in 329 (70.3%) patients, and initial antibiotics were administered to 320 (68.4%) patients. Repeated lactate measurements were performed in 277 (59.2%) patients within six hours of the first measurement. Initial fluid resuscitation (more than 30 mL/kg of crystalloid) was performed in 376 (80.3%) patients, most often using normal saline (82.7%). CVP and ScvO2 were measured in 318 (68.0%) and 103 (22.0%) patients within six hours of the time of hypotension or lactate elevation, respectively. The compliance with the application of vasopressors for achievement of mean arterial pressure ≥ 65 mmHg was 97.9%. The median time from ED arrival to first vasopressor administration, most commonly norepinephrine, was 1.9 (IQR, 1.0 to 3.5) hours. Mechanical ventilation was applied in 151 (32.3%) patients and renal replacement therapy was used in 73 (15.6%) patients. The median time from ED arrival to first source control was 15.6 (IQR, 7.2 to 47.9) hours. Among patients who underwent intervention for source control, 43 (36.8%) received intervention within 12 hours of their ED arrival. Between survivors and non-survivors, there were significant differences in interventions, including time to lactate measurement, time to blood culture, use of synthetic colloids, time to the first vasopressor, use of a second vasopressor, transfusion, mechanical ventilation, and renal replacement therapy.
Outcomes
The in-hospital, 28-day, and 90-day mortality rates were 22.9%, 21.8%, and 27.1%, respectively ( Table 5 ). The intensive care unit admission rate from the ED was 64.5%. The median length of stay in the ED, intensive care unit, and hospital ward were 6.8 (IQR, 4.0 to 14.6) hours, 4 (IQR, 2 to 8) days, and 12 (IQR, 7 to 21) days, respectively.
DISCUSSION
This preliminary analysis of a prospective, observational registry of 10 EDs participating in the KoSS is the first multi-center study about septic shock in EDs of Korea. The study mainly investigated the demographic characteristics, interventions, and clinical outcomes of patients with septic shock presenting with refractory hypotension or hyperlactatemia.
Mortality rates vary according to inclusion criteria and septic shock definition.
14 Overall, the mortality trend in sepsis or septic shock patients is declining, but mortality remains high. 4, 5, 15 Recent large clinical trials (the Australasian Resuscitation in Sepsis Evaluation study and the Protocolised Management in Sepsis trial), multi-center, ED-based studies for patients with septic shock, have reported 15.0% to 25.1% in-hospital mortality and 15.3% to 24.6% 28-day mortality. 8, 10 Our study, with similar inclusion criteria to these trials, showed comparable mortality rates. According to a global observation study (the International Multicentre Prevalence Study on Sepsis, including 1,794 patients from 62 countries), compliance with the sepsis bundle metrics remains low and variable. 16 Compliance rates were comparable in interventions including blood culture, antibiotic administration, application of vasopressor, CVP measurement, and repeated lactate measurement. However, higher compliance rates were observed for initial lactate measurement and initial fluid resuscitation. ScvO2 was relatively underused; the practice was probably affected by the current trials for early goal-directed therapy. [8] [9] [10] There are some controversies regarding whether sepsis bundle compliance directly improves outcomes and whether specific interventions or protocols are superior to management by clinical assessment. 3 However, considering the clinical importance of early recognition and timely management of septic shock, compliance to the sepsis bundle might be associated with clinical improvement in the quality of initial treatment and better outcomes. 17, 18 From this perspective, we observed that some interventions for sepsis care might need to be improved, including obtaining a blood culture, antibiotic administration, and source control interventions. Our inclusion criteria varied from the new definition of septic shock from Sepsis-3. 19 However, the new definition is relatively specific and difficult to apply in the ED. Refractory hypotension and hyperlactatemia are criteria currently recommended by the SSC guidelines for the initiation of aggressive management. 6 In Eight cases with withdrawal of supportive care were included.
Septic shock registry report addition, we have been collecting data about the Sepsis-3 definition and future studies from the KoSS registry will include these results.
There are some changes in the updated 2016 SSC guidelines. 20 CVP and ScvO2 are no longer recommended as the initial goals of resuscitation. However, the use of these targets may be considered because current trials including less severely ill patients have reported that no harm was associated with the interventional strategies. [8] [9] [10] 20 The guidelines also recommend frequent reassessment of hemodynamic status using available physiologic variables and that dynamic rather than static variables be used to predict fluid responsiveness. The KoSS registry needs to reflect these recent changes. This study has several limitations. Further data collection and analysis are needed because this is a preliminary, descriptive study; thus, the observed findings are limited. We hope that this study will lead to a large-scale study involving more hospitals and patients that will contribute to advances in the diagnosis and treatment of septic shock. Second, a number of patients were excluded from this study for several reasons and we focused on early septic shock patients in the ED, which might have led to selection bias. Third, the enrollment periods and case volumes varied according to hospital. Institutional characteristics should also be investigated in future studies.
In conclusion, in the KoSS septic shock registry, which included 10 EDs, the mortality rate of patients with septic shock exceeded 20%. The results of this preliminary report suggest that there are areas for improvement in terms of the quality of initial resuscitation and the outcomes of patients with septic shock in the ED.
